Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Copper vs LNG IUDs on Vaginal Microbiota in Young African Women
NCT07627958Not yet recruiting
- Sponsor
- Seattle Children's
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag in pregnancy and sexually transmitted infections (STI) (2 arms), sponsored by Seattle Children's. Primary endpoints: Vaginal microbial Shannon alpha diversity at 12 months and Bray-Curtis distances (Beta diversity) at 12 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
pregnancysexually transmitted infections (STI)
Beyond the preview
Go deeper on NCT07627958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07627958.